Select Committee on Health Minutes of Evidence


Examination of Witnesses (Questions 140-159)

DR STEVE STOTESBURY, MS CHRISTINE MOHRMANN AND MR BARRY JENNER

20 OCTOBER 2005

  Q140  Dr Naysmith: You must be aware of the history of direct smoking and inhaling tobacco over the years. People have denied, your industry has denied, that it had any effect, and then there was an accumulation of evidence and an accumulation of evidence until it is now impossible for anyone to maintain that smoking tobacco does not cause a variety of diseases. Do you not think the same thing is going to apply to inhaling second-hand smoke?

  Dr Stotesbury: No.

  Q141  Dr Naysmith: Is that not the most likely outcome of the current observations? Would it be right that you are trying to hold the tide back?

  Dr Stotesbury: No, I do not think so. In fact, I think some of the most recent studies have been the most convincing in terms of throwing some doubt over the relationship between ETS and various diseases. I would point particularly to a study that was published in the British Medical Journal just two years ago by Enstrom and Kabat, which was a major study of over 120,000 Californians over a 40-year period. The authors found that the association between ETS, lung cancer and heart disease was considerably weaker than generally believed.

  Q142  Dr Naysmith: They did not find that it did not exist. They may have suggested that it was weaker than had previously been suggested.

  Dr Stotesbury: They found absolutely no difference between groups exposed to environmental tobacco smoke and control groups. There was absolutely no difference at all.

  Q143  Dr Stoate: You have made some very strong statements. You say there is no statistical link between these diseases and environmental tobacco smoke, but there is extremely strong evidence in children, for example, of cot death, glue ear, respiratory diseases that can be very closely linked to cotinine levels in families, and this is very compelling evidence. For you to say there is no statistical evidence I think is misleading.

  Dr Stotesbury: I do not think I said there is no statistical evidence.

  Q144  Dr Stoate: You did say that.

  Dr Stotesbury: No. I said the statistical evidence, taken as a whole, is inconclusive.

  Q145  Dr Stoate: You cannot take it as a whole. I am talking about children's health, I am talking about cot death, glue ear, respiratory illness. You cannot say there is no statistically compelling evidence that those are attributable in large measure to environmental tobacco smoke. There is a very, very close relationship.

  Dr Stotesbury: If you listened to the previous evidence session, even the people giving evidence were only talking about risk in association with lung cancer and heart disease.

  Q146  Dr Stoate: They were looking at the big four killers in adults. I am specifically focusing on the health effects on children. You have said there is no compelling statistical evidence and I am saying that actually there is, and, with children in particular, the evidence is very strong.

  Dr Stotesbury: I heard them say there is not much evidence on other diseases.

  Q147  Dr Stoate: You are a scientific officer. You are a trained person. Are you saying they got it wrong? Are you saying they misled us? Are you saying the evidence has been interpreted wrongly? I am not clear exactly what you are saying.

  Dr Stotesbury: I am saying there is insufficient evidence.

  Q148  Dr Stoate: I have to disagree to that. I think particularly with children there is evidence. We will ask our advisers to produce some strong evidence for us.

  Dr Stotesbury: Could I refer to a study by IARC which was published in 1998 which specifically looked at that question you raise, disease in relation to children. Whilst they found a statistical association in adults that was non-significant—and I can explain that certainly, if you like—they found no evidence at all of any childhood exposure and disease.

  Q149  Dr Stoate: We will certainly ask our advisers to get that paper out for us and we will look at that.

  Dr Stotesbury: I can send you that paper, if you wish.

  Dr Stoate: That would be helpful.

  Q150  Chairman: Dr Stotesbury, have you read recently in the BMJ that Winkel et al found a highly significant risk of heart disease. It is allegedly a good study in that respect. Have you looked at that evidence at all?

  Dr Stotesbury: Yes, I have looked at that evidence.

  Q151  Chairman: Do you think that is not significant?

  Dr Stotesbury: I said earlier on that the vast majority of the scientific evidence is not flawed. I think that paper in particular is. They took blood samples that were 20 years old from the deepfreeze, and looked at responses to questionnaires recalling over that time. I think you have to call some of that method into question.

  Q152  Chairman: Could I say for the record that in the written evidence that will be published today you did use the phrase, "based on flawed science". So"flawed" was a word that came out of yourmemorandum and not out of the office of thisCommittee. Could I move on now to MsMohrmann. You say in your memorandum that you accept the need for some restrictions on smoking in public in order to protect non-smokers from the harmful effects of second-hand smoke. Do you believe that ventilation can provide adequate protection for non-smokers and employees in the smoking environment? If you do, what evidence do you have for that?

  Ms Mohrmann: We believe that ventilation is a solution for creating a comfortable environment. We do not believe ventilation should be the basis for regulation. However, it should be an option that a business owner can consider if they are going to allow smoking within their establishment.

  Q153  Chairman: Do you have evidence of that?

  Ms Mohrmann: We just think it is a solution for business owners who like to have smoking in their establishment, just as it is if they like to have separate rooms or separate areas, but it is up to that business owner to take a decision on how they want to develop their smoking policy.

  Q154  Chairman: I accept that very well, but the issue around smoking and its harmful effects and everything else—and you are familiar with it because you are a lot closer than certainly most of us in this room—is more scientific than "think". We have tried, with different witnesses in this session this morning, to get to the science of it. You think that ventilation might be better but do you have any hard study that has been done in relation to ventilation?

  Ms Mohrmann: We believe it is up to the business owner to decide what is best to accommodate their customers, smokers and non-smokers. Ventilation may be a solution. We also think that signage, for instance, is very important. It communicates the policy that that establishment has and we also believe that Government should also require on that signage that government and public health officials have concluded that second-hand smoke is harmful to non-smokers. This way, anyone entering an establishment can then make a decision about whether they want to frequent it or not.

  Q155  Dr Naysmith: You said it provides a more comfortable environment. Is that not the case? That is what you said, is it not?

  Ms Mohrmann: Yes.

  Q156  Dr Naysmith: It was not that it had any effect on reducing incidents of any kind of disease or anything, it was that it created a more comfortable environment for patrons.

  Ms Mohrmann: Yes.

  Q157  Dr Naysmith: That is what you said.

  Ms Mohrmann: Yes.

  Q158  Chairman: Mr Jenner, do you have any views on ventilation?

  Mr Jenner: Yes, Mr Chairman. We welcome the opportunity to participate in your deliberations. Our view is that ventilation does have a role to play. It would seem to us that it is commonsense that ventilation is better than no ventilation. It is a mechanism that is widely employed in other Member States in the European Union. Our company, through the BSRIA (Building Service Research Information Association) and other tobacco companies, is engaged to better understand the benefits of ventilation in a controlled environment. We would quote this as an example where we try to work with the hospitality associations, as we have done through the AIR Campaign (Atmosphere Improves Results). In our fundamental view, it is about getting rid of the smoke and not the smokers. In this way, we can support the notion that we can balance people's responsibilities with their freedoms.

  Q159  Dr Stoate: Are you saying that ventilation is about adequate protection both for non-smokers in establishments and employees? The evidence we have heard this morning on BM2.5 from the Royal College of Physicians entirely contradicts that. They would say, and I believe Mrs Rawlins said the same, that it improves comfort and the perception of a clean atmosphere. Does it provide adequate protection for non-smokers and employees? Yes or no.

  Mr Jenner: I do not think it can be summed up as easily as that, because I do not think I used the word "adequate". I was at pains to share with you that I do not think it is fully understood, the benefit. Our view is that it is commonsense that to have ventilation is better than none.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2005
Prepared 19 December 2005